Mawer Investment Management’s ResMed RMD Stock Holding History

Mawer Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.9M	Buy	84,007 +11,053	+15%	+$2.75M	0.12%	88
2025 Q4	$17.6M	Sell	72,954 -4,582	-6%	-$1.17M	0.1%	84
2025 Q3	$21.2M	Sell	77,536 -434	-0.6%	-$119K	0.11%	84
2025 Q2	$20.1M	Sell	77,970 -2,710	-3%	-$646K	0.1%	86
2025 Q1	$18.1M	Sell	80,680 -6,763	-8%	-$1.58M	0.09%	81
2024 Q4	$20M	Buy	87,443 +10,889	+14%	+$2.62M	0.09%	79
2024 Q3	$18.7M	Buy	76,554 +2,394	+3%	+$535K	0.09%	77
2024 Q2	$14.2M	Buy	74,160 +21,306	+40%	+$4.32M	0.07%	81
2024 Q1	$10.5M	Buy	52,854 +30,764	+139%	+$5.64M	0.05%	79
2023 Q4	$3.8M	Buy	+22,090	New	+$3.39M	0.02%	88

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mawer Investment Management's RMD Position: Q1 2026 in Review

Mawer Investment Management increased its ResMed (RMD) stake by 15% in Q1 2026, buying an estimated $2.75M and bringing the position to 84,007 shares worth $18.9M. The position accounts for 0.12% of the portfolio, ranked #88.

Mawer Investment Management first reported a position in RMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $21.2M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Mawer Investment Management held 84,007 shares of ResMed worth $18.9M as of Q1 2026.
Mawer Investment Management bought 11,053 ResMed shares in Q1 2026, an estimated $2.75M.
ResMed made up 0.12% of Mawer Investment Management's portfolio in Q1 2026, its #88 holding.
Mawer Investment Management first reported a position in ResMed in Q4 2023 and has held it in 10 quarters since.
Mawer Investment Management's ResMed position peaked at $21.2M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Mawer Investment Management's 13F filing for Q1 2026, filed 6 May 2026.